J. Goldman & Co’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,664
| Closed | -$573K | – | 423 |
|
|
2025
Q1 | $573K | Buy |
+14,664
| New | +$573K | 0.01% | 257 |
|
|
2024
Q4 | – | Sell |
-16,162
| Closed | -$815K | – | 421 |
|
|
2024
Q3 | $815K | Sell |
16,162
-2,005
| -11% | -$101K | 0.02% | 215 |
|
|
2024
Q2 | $799K | Buy |
18,167
+1,060
| +6% | +$46.6K | 0.02% | 221 |
|
|
2024
Q1 | $859K | Buy |
+17,107
| New | +$859K | 0.03% | 194 |
|